Our Mission
At Harness Therapeutics we have one mission: to develop disease-modifying therapies for neurodegenerative diseases that deliver meaningful, lasting impact for patients.
We are advancing the next generation of precision therapies to transform outcomes in hard-to-treat neurodegenerative diseases through controlled modulation of important CNS targets
We are driven by a deep commitment to develop effective treatments for neurodegenerative diseases – devastating conditions that impact millions and currently have few, if any, options to slow or halt their progression.
Learn more here.
- Harness has a world-class team, with leading expertise in RNA biology and translation of novel therapeutics for neurodegenerative diseases. Find out more here.
- At the heart of the Company’s innovation is finely controlled, targeted protein modulation that is unlocking disease-modifying targets, find out more about our proprietary MISBA® platform here.
- We are advancing a portfolio of programmes for large neurodegenerative disorders including Huntington’s disease, Parkinson’s disease, Alzheimer’s disease and ALS.